BIOtechnology Applied to Renal TRansplantation With IMmunobiogram

计划入组 443 人 · 首次发布于 2023 年 4 月 18 日

Limited Versus No-limited Shoulder Movement in Breast Cancer Surgery

计划入组 465 人 · 首次发布于 2019 年 1 月 8 日

Limited-duration Teclistamab

计划入组 75 人 · 首次发布于 2023 年 7 月 6 日

Liraglutide biosimilar(Biocon Limited)

Botulism Antitoxin (Sanofi Pasteur Limited)

Teriparatide biosimilar(Theramex Ireland Limited)

EVIVE BIOTECHNOLOGY IRELAND LIMITED

Ireland

Puma Biotechnology

United States

MAIA Biotechnology

United States

Avecho Biotechnology Advances CBD Insomnia Treatment with Phase III Trials and Manufacturing Expansion

Avecho Biotechnology Advances Phase III CBD-Insomnia Trial Despite Initial Recruitment Challenges

Avecho Biotechnology Reports Potential Phase III Success for CBD-Based Insomnia Treatment